Evidence map›Paper›PMID 41595940›Full record

ArticleBioengineering (Basel, Switzerland)2025

Subclass-Aware Contrastive Semi-Supervised Learning for Inflammatory Bowel Disease Classification from Colonoscopy Images.

Kechen Lin, Guangcong Ruan, Xiaoyang Zou, Yongjian Nian, Yanling Wei, Guoyan Zheng

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kechen LinDepartment of Gastroenterology, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing 400042, China.
Guangcong RuanDepartment of Gastroenterology, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing 400042, China.
Xiaoyang ZouInstitute of Medical Robotics, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China.
Yongjian NianDepartment of Digital Medicine, School of Biomedical Engineering and Imaging Medicine, Army Medical University (Third Military Medical University), Chongqing 400038, China.
Yanling WeiDepartment of Gastroenterology, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing 400042, China.
Guoyan ZhengInstitute of Medical Robotics, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China.ORCID 0000-0003-4173-0379

Funding

Chongqing Excellence Program for Innovation and Entrepreneurship Leadership Talent Project CQYC20220303576National Nature Science Foundation of China 62471293Natural Science Foundation of Chongqing, China CSTB2024NSCQ-LZX0141the Program of Chongqing Technology Innovation and Application Development CSTB2022TIAD-KPX0161
6 · The paper itself

Abstract

Inflammatory bowel disease (IBD) includes Crohn's disease (CD) and ulcerative colitis (UC). The accurate classification of IBD from colonoscopy images is critical for diagnosis and treatment. However, the lack of labeled data poses a major challenge for developing deep learning-based IBD classification approaches. Recently, pseudo-labeling-based semi-supervised learning methods offer a promising solution in leveraging both labeled and unlabeled data to improve classification performance. Nevertheless, due to significant intra-class variability and the subtle inter-class differences in IBD colonoscopy images, pseudo-labels are often inaccurate, which results in confirmation bias and suboptimal performance. To address this challenge, a Subclass-Aware Contrastive Semi-Supervised Learning method, referred to as SACSSL, is proposed for accurate IBD classification by integrating a subclass-aware contrastive module into a pseudo-labeling-based semi-supervised framework, e.g., FixMatch. Specifically, unlabeled samples are first partitioned into confident and uncertain samples according to the confidence of pseudo-labels. An instance-level contrastive loss is then applied to uncertain samples, aiming to mitigate confirmation bias. Furthermore, intra-class heterogeneity is captured by introducing a set of prototypes for each subclass and assigning confident samples to these prototypes to form fine-grained subclasses, and supervised contrastive loss is applied to promote intra-subclass clustering, thereby enhancing inter-class separability while preserving intra-class diversity. Our method is evaluated on two datasets, i.e., an in-house collected Daping dataset for IBD classification and a publicly available LIMUC dataset for UC severity grading. On both datasets, our method achieves state-of-the-art performance under the semi-supervised setting. Specifically, with only 20% labeled data, the proposed method reaches an overall accuracy of 93.2% and an F1-score of 80.1% on the Daping dataset, which is close to the fully supervised upper bound (94.0% accuracy and 80.8% F1-score), and it achieves an overall accuracy of 76.4% and an F1-score of 68.9% on the LIMUC dataset. Comprehensive experimental results demonstrate the effectiveness of our method for semi-supervised colonoscopy image classification.

Indexed as

colonoscopy imagescontrastive learninginflammatory bowel diseasesemi-supervised learning

Identifiers

PMID41595940
PMCPMC12838207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.